臨牀消化器内科 Vol.23 No.3(8)


特集名 胃癌スクリーニングの現況とハイリスクストラテジー
題名 ハイリスクストラテジーとしてのべプシノゲン法
発刊年月 2008年 03月
著者 三木 一正 東邦大学医学部医学科内科学講座 (大森) 消化器内科
著者 笹島 雅彦 ひもんや内科・消化器科診療所
【 要旨 】 ペプシノゲン (PG) 法の精度や胃癌死亡率減少効果の研究を行ってきた.これまでの研究成果をふまえ,胃癌対策としての総合的な経済学的評価を行ったうえで,PG法を用いた胃癌スクリーニングのハイリスクストラテジーによる経済的でかつ胃癌死亡減少をもたらすマネージメント方法を提案した.(1) PG法による胃がん検診実施地域の資料をもとに,観察的手法である症例・対照研究 (13年間遡及) で,PG法単独による胃癌死亡率減少効果を確認できた.(2) PG法,胃X線法 (DR) 併用胃がん検診を行い,PG法とX線法の精度および費用対効果の検討で,PG法の精度は直接X線法とはほぼ同等であること,およびPG法とX線検査を組み合わせる検診方法の合理性・有用性が示された.(3) Helicobacter pylori (H. pylori) 抗体価,PG法併用胃がん検診 (健常人男性10年間追跡) での年率胃癌発生数およびハザード比の検討で,H. pylori感染のない群 [A群 : H. pylori(-),PG (-)] から胃癌発生が10年間みられず,A群を低リスク群として胃がん検診対象から外し,萎縮性胃炎合併症群 (B,C,D群) を選択的にスクリーニングする胃がん検診の合理性が示された.今後は,このH. pylori抗体価・PG法併用胃がん検診 (ABCD検診) を全国的に推進・普及させることで,胃がん検診の効率化がなされ,経済的でかつ胃癌死亡減少をもたらす胃がん検診となることが強く期待される.
結論 : 胃癌対策として推奨する胃がん検診方式は,「一次スクリーニングはH. pylori抗体測定とPG法で行い,二次スクリーニングは内視鏡 (極細径や経鼻) 検査」である.
Theme Gastric Cancer Screening -- Present Status and Uprising High-risk Strategy
Title Pepsinogen Test Method as High Risk Strategy
Author Kazumasa Miki Division of Gastroenterology & Hepatology, Department of Internal Medicine (Ohmori), School of Medicine, Faculty of Medicine, Toho University
Author Masahiko Sasajima Himonya Medical-Gastroenterological Clinic
[ Summary ] A study was previously conducted on the accuracy of the pepsinogen (PG) method and its effectiveness in reducing mortality rates for stomach cancer. A stomach cancer screening system was developed which is economically feasible for bringing about a reduction in stomach cancer mortality rates. A high risk strategy for stomach cancer screening was adopted. It was used after conducting a comprehensive economic evaluation and is considered to be an effective countermeasure for stomach cancer in relation to previous research findings. These findings are as follows : (1) The effectiveness of reducing stomach cancer mortality rates using the PG method alone was confirmed using an observation technique in the form of a case-control study (retrospectively over the course of 13 years) based on data obtained from areas implementing stomach cancer examinations using the PG method. (2) The accuracy of the PG method was demonstrated to be nearly equal to that of X-rays (digital radiography ; DR). Examinations combining the PG and X-ray metbods were found to be both feasible and useful in a study of the accuracy and cost effectiveness of the PG and X-ray methods by conducting stomach cancer examinations combining the PG method and X-ray method (DR). (3) In a study of the annual incidence of stomach cancer and the hazard ratio for stomach cancer examinations combining assays of Helicobacter pylori (Hp) antibody levels and the PG method (follow-up study on healthy males over a period of 10 years), stomach cancer was observed to not have occurred for 10 years in a group free of Hp infection (Group A : Hp (-). PG (-)), this Group A was designated as a low risk group and excluded from stomach cancer examinations. Stomach cancer examinations consisting of selective screening for groups with atrophic gastritis complications (Groups B, C and D) were demonstrated to be feasible. In the future, it is strongly hoped that the efficiency of stomach cancer examinations will be improved and that stomach cancer examinations which are economical, while also bringing about a reduction in stomach cancer mortality rates, will be implemented by promoting and expanding the number of stomach cancer examinations combining assays of Hp antibody levels. The role of the PG method, as described above, should be expanded on a national scale. In conclusion, the use of assays of Hp antibody levels and the PG method for primary screening, as well as the use of endoscopic examinations (small diameter or transnasal) for secondary screening is considered to be the recommended approach for stomach cancer examinations, providing countermeasures against stomach cancer.
戻る